Autologous adipose-derived stromal vascular fraction (Mayo Clinic)

自体脂肪源基质血管组分细胞（梅奥诊所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAutologous adipose-derived stromal vascular fraction (Mayo Clinic)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacementsTissue replacements
TargetsNot applicable
Therapy Area/IndicationsTracheoesophageal FistulaOsteoarthritis, KneeArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsTracheoesophageal FistulaOsteoarthritis, KneeArthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A